首页 > 市场调查报告书 > 医疗设备

体外诊断生技设备

市场调查报告书

商品编码

1905177

日本组织诊断市场报告（按产品类型、技术、疾病、最终用户和地区划分，2026-2034 年）

Japan Tissue Diagnostics Market Report by Product Type, Technology, Disease, End User, and Region 2026-2034

出版日期: 2026年01月01日 | 出版商:

IMARC | 英文 117 Pages | 商品交期: 5-7个工作天内

价格

简介目录

2025年，日本组织诊断市场规模达2.59亿美元。展望未来， IMARC Group预计到2034年，该市场规模将达到4.464亿美元，2026年至2034年期间的复合年增长率（CAGR）为6.24%。数位病理学、次世代定序（NGS）和先进影像技术等技术的不断进步，提高了组织诊断的准确性和效率，是推动市场成长的主要因素。

本报告解答的关键问题：

日本组织诊断市场目前表现如何？未来几年又将如何发展？
新冠疫情对日本组织诊断市场产生了哪些影响？
日本组织诊断市场依产品类型分類的组成是怎样的？
日本组织诊断市场依技术分類的组成是怎样的？
日本组织诊断市场依疾病分类的组成是怎样的？
日本组织诊断市场依最终使用者分類的组成是怎样的？
日本组织诊断市场价值链的各个阶段有哪些？
日本组织诊断的关键驱动因素和挑战是什么？
日本组织诊断市场的结构是怎么样的？主要参与者有哪些？
日本组织诊断市场的竞争程度如何？

Japan tissue diagnostics market size reached USD 259.0 Million in 2025. Looking forward, IMARC Group expects the market to reach USD 446.4 Million by 2034, exhibiting a growth rate (CAGR) of 6.24% during 2026-2034. The rising advances in technology, such as digital pathology, next-generation sequencing (NGS), and advanced imaging techniques, which have improved the accuracy and efficiency of tissue diagnostics, are driving the market.

Tissue diagnostics is a crucial field in medicine that involves the microscopic examination and analysis of tissue samples to diagnose diseases and provide insights into their underlying causes. It plays a fundamental role in identifying various medical conditions, including cancer, infections, inflammatory disorders, and autoimmune diseases. The process typically begins with the collection of tissue specimens obtained through procedures like biopsies or surgeries. These samples are then processed, embedded in paraffin wax, sliced into thin sections, and stained with specific dyes to enhance visibility under a microscope. Skilled pathologists and histotechnologists examine these stained tissue sections to identify abnormal cellular structures, patterns, and markers. Tissue diagnostics help clinicians make informed decisions about patient treatment plans, including the choice of therapies, surgeries, or medications. Advances in technology, such as immunohistochemistry and molecular testing, have further improved the precision and specificity of tissue diagnostics, enabling personalized medicine approaches. This field continues to evolve, contributing significantly to early disease detection, prognosis prediction, and tailored patient care.

Japan Tissue Diagnostics Market Trends:

The tissue diagnostics market in Japan is experiencing substantial growth, primarily driven by several key factors. Firstly, the increasing prevalence of cancer necessitates advanced diagnostic techniques, fostering a surge in demand for tissue diagnostics. Additionally, the burgeoning geriatric population, who are more susceptible to chronic diseases, further propels this demand. Furthermore, technological advancements in the realm of molecular diagnostics have revolutionized tissue-based testing, rendering it more efficient and accurate. Also, there has been a significant rise in the awareness of personalized medicine among patients and healthcare providers alike. This has led to an increased emphasis on early disease detection and treatment customization, emphasizing the critical role of tissue diagnostics. Moreover, initiatives by government and private organizations to provide funding and grants for research in cancer diagnostics undeniably spur market growth. Apart from this, the continuous evolution in biomarker identification that is bolstering the development of new diagnostic tools is expected to drive the tissue diagnostics market in Japan.

Japan Tissue Diagnostics Market Segmentation: -

Product Type Insights:

Instruments
Consumables

Technology Insights:

Immunohistochemistry
In Situ Hybridization
Digital Pathology and Workflow Management
Special Staining

Disease Insights:

Breast Cancer
Gastric Cancer
Lymphoma
Prostate Cancer
Non-Small Cell Lung Cancer
Others

End User Insights:

Hospitals
Research Laboratories
Pharmaceutical Companies
Contract Research Organizations
Others

Regional Insights:

Kanto Region
Kansai/Kinki Region
Central/ Chubu Region
Kyushu-Okinawa Region
Tohoku Region
Chugoku Region
Hokkaido Region
Shikoku Region
The report has also provided a comprehensive analysis of all the major regional markets, which include Kanto Region, Kansai/Kinki Region, Central/ Chubu Region, Kyushu-Okinawa Region, Tohoku Region, Chugoku Region, Hokkaido Region, and Shikoku Region.

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape in the market. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

Key Questions Answered in This Report:

How has the Japan tissue diagnostics market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the Japan tissue diagnostics market?
What is the breakup of the Japan tissue diagnostics market on the basis of product type?
What is the breakup of the Japan tissue diagnostics market on the basis of technology?
What is the breakup of the Japan tissue diagnostics market on the basis of disease?
What is the breakup of the Japan tissue diagnostics market on the basis of end user?
What are the various stages in the value chain of the Japan tissue diagnostics market?
What are the key driving factors and challenges in the Japan tissue diagnostics?
What is the structure of the Japan tissue diagnostics market and who are the key players?
What is the degree of competition in the Japan tissue diagnostics market?

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Japan Tissue Diagnostics Market - Introduction

4.1 Overview
4.2 Market Dynamics
4.3 Industry Trends
4.4 Competitive Intelligence

5 Japan Tissue Diagnostics Market Landscape

5.1 Historical and Current Market Trends (2020-2025)
5.2 Market Forecast (2026-2034)

6 Japan Tissue Diagnostics Market - Breakup by Product Type

6.1 Instruments
- 6.1.1 Overview
- 6.1.2 Historical and Current Market Trends (2020-2025)
- 6.1.3 Market Forecast (2026-2034)
6.2 Consumables
- 6.2.1 Overview
- 6.2.2 Historical and Current Market Trends (2020-2025)
- 6.2.3 Market Forecast (2026-2034)

7 Japan Tissue Diagnostics Market - Breakup by Technology

7.1 Immunohistochemistry
- 7.1.1 Overview
- 7.1.2 Historical and Current Market Trends (2020-2025)
- 7.1.3 Market Forecast (2026-2034)
7.2 In Situ Hybridization
- 7.2.1 Overview
- 7.2.2 Historical and Current Market Trends (2020-2025)
- 7.2.3 Market Forecast (2026-2034)
7.3 Digital Pathology and Workflow Management
- 7.3.1 Overview
- 7.3.2 Historical and Current Market Trends (2020-2025)
- 7.3.3 Market Forecast (2026-2034)
7.4 Special Staining
- 7.4.1 Overview
- 7.4.2 Historical and Current Market Trends (2020-2025)
- 7.4.3 Market Forecast (2026-2034)

8 Japan Tissue Diagnostics Market - Breakup by Disease

8.1 Breast Cancer
- 8.1.1 Overview
- 8.1.2 Historical and Current Market Trends (2020-2025)
- 8.1.3 Market Forecast (2026-2034)
8.2 Gastric Cancer
- 8.2.1 Overview
- 8.2.2 Historical and Current Market Trends (2020-2025)
- 8.2.3 Market Forecast (2026-2034)
8.3 Lymphoma
- 8.3.1 Overview
- 8.3.2 Historical and Current Market Trends (2020-2025)
- 8.3.3 Market Forecast (2026-2034)
8.4 Prostate Cancer
- 8.4.1 Overview
- 8.4.2 Historical and Current Market Trends (2020-2025)
- 8.4.3 Market Forecast (2026-2034)
8.5 Non-Small Cell Lung Cancer
- 8.5.1 Overview
- 8.5.2 Historical and Current Market Trends (2020-2025)
- 8.5.3 Market Forecast (2026-2034)
8.6 Others
- 8.6.1 Historical and Current Market Trends (2020-2025)
- 8.6.2 Market Forecast (2026-2034)

9 Japan Tissue Diagnostics Market - Breakup by End User

9.1 Hospitals
- 9.1.1 Overview
- 9.1.2 Historical and Current Market Trends (2020-2025)
- 9.1.3 Market Forecast (2026-2034)
9.2 Research Laboratories
- 9.2.1 Overview
- 9.2.2 Historical and Current Market Trends (2020-2025)
- 9.2.3 Market Forecast (2026-2034)
9.3 Pharmaceutical Companies
- 9.3.1 Overview
- 9.3.2 Historical and Current Market Trends (2020-2025)
- 9.3.3 Market Forecast (2026-2034)
9.4 Contract Research Organizations
- 9.4.1 Overview
- 9.4.2 Historical and Current Market Trends (2020-2025)
- 9.4.3 Market Forecast (2026-2034)
9.5 Others
- 9.5.1 Historical and Current Market Trends (2020-2025)
- 9.5.2 Market Forecast (2026-2034)

10 Japan Tissue Diagnostics Market - Breakup by Region

10.1 Kanto Region
- 10.1.1 Overview
- 10.1.2 Historical and Current Market Trends (2020-2025)
- 10.1.3 Market Breakup by Product Type
- 10.1.4 Market Breakup by Technology
- 10.1.5 Market Breakup by Disease
- 10.1.6 Market Breakup by End User
- 10.1.7 Key Players
- 10.1.10 Market Forecast (2026-2034)
10.2 Kansai/Kinki Region
- 10.2.1 Overview
- 10.2.2 Historical and Current Market Trends (2020-2025)
- 10.2.3 Market Breakup by Product Type
- 10.2.4 Market Breakup by Technology
- 10.2.5 Market Breakup by Disease
- 10.2.6 Market Breakup by End User
- 10.2.7 Key Players
- 10.2.8 Market Forecast (2026-2034)
10.3 Central/ Chubu Region
- 10.3.1 Overview
- 10.3.2 Historical and Current Market Trends (2020-2025)
- 10.3.3 Market Breakup by Product Type
- 10.3.4 Market Breakup by Technology
- 10.3.5 Market Breakup by Disease
- 10.3.6 Market Breakup by End User
- 10.3.7 Key Players
- 10.3.8 Market Forecast (2026-2034)
10.4 Kyushu-Okinawa Region
- 10.4.1 Overview
- 10.4.2 Historical and Current Market Trends (2020-2025)
- 10.4.3 Market Breakup by Product Type
- 10.4.4 Market Breakup by Technology
- 10.4.5 Market Breakup by Disease
- 10.4.6 Market Breakup by End User
- 10.4.7 Key Players
- 10.4.8 Market Forecast (2026-2034)
10.5 Tohoku Region
- 10.5.1 Overview
- 10.5.2 Historical and Current Market Trends (2020-2025)
- 10.5.3 Market Breakup by Product Type
- 10.5.4 Market Breakup by Technology
- 10.5.5 Market Breakup by Disease
- 10.5.6 Market Breakup by End User
- 10.5.7 Key Players
- 10.5.8 Market Forecast (2026-2034)
10.6 Chugoku Region
- 10.6.1 Overview
- 10.6.2 Historical and Current Market Trends (2020-2025)
- 10.6.3 Market Breakup by Product Type
- 10.6.4 Market Breakup by Technology
- 10.6.5 Market Breakup by Disease
- 10.6.6 Market Breakup by End User
- 10.6.7 Key Players
- 10.6.8 Market Forecast (2026-2034)
10.7 Hokkaido Region
- 10.7.1 Overview
- 10.7.2 Historical and Current Market Trends (2020-2025)
- 10.7.3 Market Breakup by Product Type
- 10.7.4 Market Breakup by Technology
- 10.7.5 Market Breakup by Disease
- 10.7.6 Market Breakup by End User
- 10.7.7 Key Players
- 10.7.8 Market Forecast (2026-2034)
10.8 Shikoku Region
- 10.8.1 Overview
- 10.8.2 Historical and Current Market Trends (2020-2025)
- 10.8.3 Market Breakup by Product Type
- 10.8.4 Market Breakup by Technology
- 10.8.5 Market Breakup by Disease
- 10.8.6 Market Breakup by End User
- 10.8.7 Key Players
- 10.8.8 Market Forecast (2026-2034)

11 Japan Tissue Diagnostics Market - Competitive Landscape

11.1 Overview
11.2 Market Structure
11.3 Market Player Positioning
11.4 Top Winning Strategies
11.5 Competitive Dashboard
11.6 Company Evaluation Quadrant

12 Profiles of Key Players

12.1 Company A
- 12.1.1 Business Overview
- 12.1.2 Product Portfolio
- 12.1.3 Business Strategies
- 12.1.4 SWOT Analysis
- 12.1.5 Major News and Events
12.2 Company B
- 12.2.1 Business Overview
- 12.2.2 Product Portfolio
- 12.2.3 Business Strategies
- 12.2.4 SWOT Analysis
- 12.2.5 Major News and Events
12.3 Company C
- 12.3.1 Business Overview
- 12.3.2 Product Portfolio
- 12.3.3 Business Strategies
- 12.3.4 SWOT Analysis
- 12.3.5 Major News and Events
12.4 Company D
- 12.4.1 Business Overview
- 12.4.2 Product Portfolio
- 12.4.3 Business Strategies
- 12.4.4 SWOT Analysis
- 12.4.5 Major News and Events
12.5 Company E
- 12.5.1 Business Overview
- 12.5.2 Product Portfolio
- 12.5.3 Business Strategies
- 12.5.4 SWOT Analysis
- 12.5.5 Major News and Events

13 Japan Tissue Diagnostics Market - Industry Analysis

13.1 Drivers, Restraints, and Opportunities
- 13.1.1 Overview
- 13.1.2 Drivers
- 13.1.3 Restraints
- 13.1.4 Opportunities
13.2 Porters Five Forces Analysis
- 13.2.1 Overview
- 13.2.2 Bargaining Power of Buyers
- 13.2.3 Bargaining Power of Suppliers
- 13.2.4 Degree of Competition
- 13.2.5 Threat of New Entrants
- 13.2.6 Threat of Substitutes
13.3 Value Chain Analysis

14 Appendix

02-2729-4219

+886-2-2729-4219

License/价格

日本组织诊断市场报告（按产品类型、技术、疾病、最终用户和地区划分，2026-2034 年）

Japan Tissue Diagnostics Market Report by Product Type, Technology, Disease, End User, and Region 2026-2034

本报告解答的关键问题：

目录

第一章：序言

第二章：范围与方法

第三章：执行概要

第四章：日本组织诊断市场－简介

第五章：日本组织诊断市场概况

第六章：日本组织诊断市场－依产品类型划分

第七章：日本组织诊断市场－依技术细分

第八章：日本组织诊断市场－依疾病分类

第九章：日本组织诊断市场－以最终用户划分

第十章：日本组织诊断市场－按地区划分

第十一章：日本组织诊断市场－竞争格局

第十二章：关键参与者简介

第十三章：日本组织诊断市场—产业分析

第十四章：附录